Potential in Medical Technology

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

... provide the basis for a broader indication. A potential second filing in Europe will involve a broader ... expertise and the momentum to realize the full potential of antisense as a drug discovery technology," ... subsidiary, and the therapeutic and commercial potential of the Company's technologies and products in ...

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

... across the blood-brain barrier, an important potential advance for small molecule therapies. The product ... current views regarding the progress and potential of the company's pipeline of proprietary drug candidates, the value and potential of the company's technology platform, and the ...

Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C

... dose. Given these characteristics and the potential benefits of nucleotide analogs over other classes ... first series of studies designed to assess the potential of combinations of small molecules without ... entitled "Risk Factors" and discussions of potential risks and uncertainties in our subsequent filings ...

Cryo-Cell Announces C'elle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.

... menstrual stem technology (MenSCs) to identify potential future diagnostic and therapeutic uses in ... new area of research that will investigate potential benefits of a new and non-invasive way to test ... will also utilize C'elle stem cells to develop potential therapies for female stress urinary incontinence, ...

Cyberonics Provides Update on Depression Post-Approval Study

... intellectual property protection and potential infringement claims; maintaining compliance with ... for new indications; product liability claims and potential litigation; reliance on single suppliers and ... previously disclosed governmental inquiries; the potential identification of material weaknesses in our ...

R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent

... statements, including statements related to the potential efficacy and commercial potential of R788 and Rigel's plans to pursue further ... and the commercialization of product candidates, potential problems that may arise in the clinical testing ...

Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA

... clinical development of LX1032 and the potential therapeutic and commercial potential of LX1032. This press release also ... preclinical and clinical development of its other potential drug candidates, advance additional candidates ...

FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

... treatment of high blood pressure. The long-term potential of Tekturna is being studied in an extensive ... or by express or implied discussions regarding potential future indications or labeling for Tekturna or Tekturna HCT, or regarding potential future revenues from Tekturna or Tekturna HCT. ...

National Cancer Institute Research Identifies Unique Mechanism of Brostallicin's Anti-Tumor Effectiveness

... in particular, including, without limitation, the potential failure of the preclinical results to predict ... of the bio-marker to guide clinical trials, the potential failure of the clinical results to predict the ... effective treatment of cancer (including the potential for liver and cardiac toxicity) , ...

Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)

... with the results of this study, which support the potential for IDX184 to be a best-in-class nucleoside/tide ... activities in hepatitis C, or any potential pipeline candidates, including any expressed or ... product candidate or other component of its potential pipeline to the clinic, to the regulatory process ...

Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study

... Metal implants. These results indicate the potential for improved long term biologic fixation with ... in-growth, decreased stress-shielding, and the potential for improved long term implant fixation. ... implants at a mid-term follow-up, and highlights potential advantages attributed to Trabecular Metal ...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

... results demonstrated that BENLYSTA has the potential to become the first new approved drug in decades ... available, patients would benefit greatly from potential new treatments. BENLYSTA is an outstanding ... will be analyzed after 52 weeks in support of a potential Biologics License Application in the United ...

University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test

... for the AttoSense HPV test, particularly the potential to close the last major gap in screening for ... as having an assay that shows great standalone potential as well as the possibility of combining with ... press release, including statements regarding potential false negatives and ...

Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)

... an up-front cash payment of $20M USD and the potential for up to $110M USD in additional payments linked ... in clinical development, Urocidin has the potential to extend and enhance our recent therapeutic ... Endo team. Equally, we are very excited about the potential returns to Bioniche and its shareholders ...

Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial

... statements, including statements related to the potential efficacy and commercial potential of R788 and Rigel's plans to pursue further ... and the commercialization of product candidates, potential problems that may arise in the clinical testing ...

Mayo Clinic Proceedings: A Comprehensive Review of Addiction to Prescription Painkillers Among Patients and Physicians

... timely. As the immense challenges, including potential tragedies, of prescription chemical addiction and ... Keen awareness by family and friends of potential addiction is crucial for physicians and other ... any suspected addiction and abuse because of the potential harm that might befall the individual and his or ...

Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis

... believes that Aganocide(R) compounds have a low potential for generating microbial resistance, offering a potential solution to the problem of rising resistance of ... expectations regarding the clinical trial and the potential efficacy of Aganocide(R) compounds are ...

New Review on PROSTVAC(TM) Published by Key Investigators From NCI

... their positive view on PROSTVAC(TM) and the potential use of the vaccine in earlier stages of ... into late stage clinical development that has the potential to extend the lives of people with advanced ... side effects. In contrast, PROSTVAC(TM) has the potential to extend survival with improved quality of life. ...

SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... step toward an approval as SIMPONI has the potential to benefit a broad range of patients in Europe by ... should be advised of and avoid exposure to potential risk factors for infection as appropriate. For ... more often than in the general population. The potential role of TNF-blocking therapy in the development ...

West Wireless Health Institute Teams with Corventis for its First Multicenter, Randomized Clinical Trial

... fluid status and respiratory rate -- there is the potential to markedly reduce the need for hospital ... by the FDA in February 2009, which sets up the potential for a multicenter, randomized clinical trial. ... "Corventis understands the tremendous potential of non-invasive wireless technology and sensors ...

Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease

... discussions with regulatory authorities and the potential goals, progress, timing and results of clinical ... of Amicus, including, without limitation: the potential that data from the phase 3 trial design for ... insufficient to support regulatory approval; the potential that results of clinical or pre-clinical studies ...

Alfacell Provides Shareholder Update

... by these results and believe Onconase has the potential to overcome multiple drug resistance (MDR). A ... researches from all over the world could be potential buyers of Onconase. We anticipate results ... in the near-term. Talks have been ongoing with potential private investors regarding recapitalizing the ...

VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease

... of leukotrienes, lowering of hsCRP, and the potential for plaque stabilization as demonstrated by ... VIA-2291; -- our ability to identify potential clinical candidates from the family of ... to our product candidates; -- our potential for future growth and the development of our ...

Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009

... Cardiovascular Safety and potential Benefits of Exenatide to be Prospectively ... cardiovascular events and that BYETTA may offer a potential cardiovascular benefit." Study Design and ... used with metformin or a thiazolidinedione, with potential weight loss. BYETTA is not a weight loss product. ...

Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections

... safety of torezolid in this trial demonstrate its potential for the rapid treatment of severe infections ... compliance Broader safety window enabling potential longer course of therapy Possibility for ... severe CAP and osteomyelitis Lower potential for drug-drug interactions including those with ...

Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial

... - Phase III study underway to explore potential of Afinitor to prevent relapse in patients with ... at 6 months(1). "We continue to see the potential of Afinitor in multiple types of cancer," said ... This worldwide study will evaluate the potential of everolimus to extend disease-free survival in ...

Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009

... sustained improvements in glycemic control, with potential weight loss," said Orville G. Kolterman, M.D., ... used with metformin or a thiazolidinedione, with potential weight loss. BYETTA is not a weight loss product. ... the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin ...

Three Surgeons in East Texas Are Successfully Integrating a Novel Stem Cell Procedure for Spine Surgeries

... the new procedure that harnesses the healing potential of adult stem cells from a patient's own body. ... is without arguments on the cutting edge; the potential outcomes utilizing this technology may create an ... surgeons and top-tier institutions support its potential advantage to aid in faster healing time and ...

CEL SCI Collaborators Demonstrate Novel L.E.A.P.S. Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other Influenzas

... be protective against tuberculosis and have the potential to treat swine and other H1N1 influenzas. ... or autoimmune diseases and allergies, are potential therapeutic or preventive sites for the ... in clinical studies, timely development of any potential products that can be shown to be safe and ...

Investigational Cancer Drug BSI-201 Showed Clinical Benefit in 62% of Patients with Triple-Negative Metastatic Breast Cancer and Significantly Prolonged Survival

... added toxicities. BSI-201 may provide a potential new treatment option for patients suffering from ... help us determine its full therapeutic potential in triple negative breast cancer, as well as in ... BSI-201 is currently being evaluated for its potential to enhance the effect of chemotherapy-induced DNA ...

Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer

... activity of PLX4032 in larger trials to support a potential registration program beginning later this year. ... strong partnership are co-developing PLX4032 for potential use in a number of cancers harbouring the BRAF ... use of biomarkers and diagnostic tools and the potential benefits of tailoring cancer treatment to ...

Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer

... were statistically significant for FOLPI as a potential neuropathy-sparing alternative to FOLFOX ... 2 safety and efficacy results, which suggest the potential of picoplatin in FOLPI as a neuropathy-sparing ... and strategic goals, drug development plans, the potential safety and efficacy of its products in ...

Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types

... taking tamoxifen - Phase II data show potential of Glivec(R) in treating patients with advanced ... when most are diagnosed(4)(5). Everolimus shows potential to help address this unmet medical need(3). ... Highlights in melanoma New data highlight the potential of two Novartis products as treatments for ...

Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research

... Expedite New Treatments from Lab to Patient with potential for Results that Impact Many Forms of Cancer ... a laser-like focus on research that has enormous potential to help patients and save lives. The Stand Up To ... and clinical applications that have extraordinary potential for patients. "For people struggling with ...

New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal

... using monoamine oxidase inhibitors (MAOI) due to potential additive effects on norepinephrine levels, which ... should be used during pregnancy ONLY if the potential benefit justifies the potential risk to the fetus. Withdrawal symptoms may ...

Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials

... beta monoclonal antibody being investigated as a potential treatment to delay the progression of mild to ... IDENTITY and IDENTITY 2 for a different potential treatment for Alzheimer's disease, a ... to date have been too short to evaluate any potential delay in the progress of Alzheimer's disease. To ...

Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)

... safety studies, we believe raxibacumab has the potential to be an important new treatment for inhalation ... darapladib, currently in Phase 3 development as a potential treatment for coronary heart disease, and ... currently in Phase 3 development as a potential treatment for type 2 diabetes. For more ...

Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business

... and similar expressions regarding the potential sale of the U.S. business and our expectations ... with the transaction and with respect to the potential sale of Encorium Oy will not result in a premium ... (xi) announced awards received from existing and potential customers are not definitive until fully ...

Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US

... an ATP-dependent potassium channel agonist with potential utility in several cardiovascular and metabolic ... clinical studies have demonstrated the drug's potential to lower triglycerides, non-HDL cholesterol and ... membrane protein whose modulation has the potential to impact a wide range of cardiovascular and ...

Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis

... development for MDX-1100 in RA, including the potential for subcutaneous dosing," said Geoffrey M. ... "We also look forward to exploring the broader potential of MDX-1100 in a range of inflammatory diseases, ... assessments, pharmacokinetics of MDX-1100, and potential biomarkers of activity. According to the ...